1. Walsh, JP . Managing thyroid disease in general practice. Med J Aust 2016; 205: 179–184.
Google Scholar | Crossref | Medline2. Shirazi, HA, Hedayati, M, Daneshpour, MS, et al. Analysis of loss of heterozygosity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families. Indian J Hum Genet 2012; 18: 340–343.
Google Scholar | Crossref | Medline3. WHO, et al., Recommendations and guidance on hepatitis C virus self-testing. WHO 2021. (https://www.who.int/publications/i/item/9789240031128)
Google Scholar4. WHO, et al., Global progress report on HIV, viral hepatitis and sexually transmitted infections. WHO 2021. (https://www.who.int/publications/i/item/9789240027077)
Google Scholar5. Antonelli, A, Ferri, C, Fallahi, P, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16: 563–572.
Google Scholar | Crossref | Medline6. Fallahi, P, Ferrari, SM, Giuggioli, D, et al. Thyroid involvement in hepatitis C-associated mixed cryoglobulinemia. Hormones (Athens) 2014; 13: 16–23.
Google Scholar | Crossref | Medline7. Hassan, MM, Kaseb, A, Li, D, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 2009; 49: 1563–1570.
Google Scholar | Crossref | Medline8. Montella, M, Pezzullo, L, Crispo, A, et al. Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol Rep 2003; 10: 133–136.
Google Scholar | Medline9. Scappaticcio, L, Longo, M, Maiorino, MI, et al. Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis. Thyroid 2021; 31: 884–894.
Google Scholar | Crossref | Medline10. Corma-Gomez, A, Macias, J, Tellez, F, et al. Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with advanced fibrosis treated with direct-acting antivirals. Clin Infect Dis 2020; 71: 2354–2362.
Google Scholar | Medline11. WHO . Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva. 2018.
Google Scholar12. DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
Google Scholar | Crossref | Medline13. Mantel, N, Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748.
Google Scholar | Medline14. Alessandro, A, Clodoveo, F, Poupak, F, et al. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17: 447–451.
Google Scholar15. Antonelli, A, Porciello, G, Marccheroni, M, et al. Thyroid cancer in patients with chronic hepatitis C virus infection. J Hepatol 2000; 32: 108–108.
Google Scholar | Crossref16. Antonelli, A, Ferri, C, Pampana, A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10–13.
Google Scholar | Crossref | Medline | ISI17. Antonelli, A, Ferri, C, Fallahi, P. Thyroid cancer in patients with hepatitis C infection. JAMA 1999; 281: 1588–1588.
Google Scholar | Crossref | Medline18. Indolfi, G, Stagi, S, Bartolini, E, et al. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol (Oxf.) 2008; 68: 117–121.
Google Scholar | Crossref | Medline19. Ishibashi, K, Katayama, K, Shinzaki, S, et al. The high prevalence of thyroid cancer in patients with hepatitis type C virus infection. Gastroenterology 2000; 118: A1450–A1450.
Google Scholar | Crossref20. Seguro Danilovic, DL, Mendes-Correa, MC, Chammas, MC, et al. Thyroid disturbance related to chronic hepatitis C infection: role of CXCL10. Endocr J 2013; 60: 583–590.
Google Scholar | Crossref | Medline21. Omland, LH, Farkas, DK, Jepsen, P, et al. Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol 2010; 2: 179–186.
Google Scholar | Crossref | Medline22. Duberg, AS, Nordström, M, Törner, A, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 2005; 41: 652–659.
Google Scholar | Crossref | Medline | ISI23. Antonelli, A, Ferri, C, Fallahi, P, et al. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17: 447–451.
Google Scholar | Crossref | Medline24. Giordano, TP, Henderson, L, Landgren, O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. Jama 2007; 297: 2010–2017.
Google Scholar | Crossref | Medline | ISI25. Wei, L, Duan, Z, Wang, G. Guidelines for prevention and treatment of hepatitis C (2019 version). J Clin Hepatol 2020; 01: 33–52.
Google Scholar26. Roccatello, D, Saadoun, D, Ramos-Casals, M, et al. Cryoglobulinaemia. Nat Rev Dis Primers 2018; 4: 1–15.
Google Scholar | Crossref | Medline27. Molleston, JP, Mellman, W, Narkewicz, MR, et al. Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2013; 56: 304–310.
Google Scholar | Crossref | Medline28. Obermayer-Straub, P, Manns, MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 2001; 16: 275–285.
Google Scholar | Crossref | Medline29. Rowan, BP, Smith, A, Gleeson, D, et al. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact? Gut 1994; 35: 542–546.
Google Scholar | Crossref | Medline30. Pateron, D, Hartmann, DJ, Duclos-Vallée, JC, et al. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1993; 17: 417–419.
Google Scholar | Crossref | Medline31. Tran, A, Quaranta, JF, Benzaken, S, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253–257.
Google Scholar | Crossref | Medline32. Baudin, E, Marcellin, P, Pouteau, M, et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf.) 1993; 39: 657–661.
Google Scholar | Crossref | Medline33. Pawlotsky, JM, Ben Yahia, M, Andre, C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841–848.
Google Scholar | Crossref | Medline34. Hadziyannis, SJ . Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci 1996; 41: 63s–74s.
Google Scholar | Crossref | Medline35. Pastore, F, Martocchia, A, Stefanelli, M, et al. Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment. World J Hepatol 2016; 8: 83–91.
Google Scholar | Crossref | Medline36. Tomer, Y, Davies, TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24: 694–717.
Google Scholar | Crossref | Medline37. Weetman, AP . Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; 148: 1–9.
Google Scholar | Crossref | Medline38. Roederer, M, Quaye, L, Mangino, M, et al. The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell 2015; 161: 387–403.
Google Scholar | Crossref | Medline | ISI39. Bech, K, Lumholtz, B, Nerup, J, et al. HLA Antigens in Graves’ disease. Acta Endocrinol (Copenh.) 1977; 86: 510–516.
Google Scholar | Crossref | Medline40. Jacobson, EM, Huber, AK, Akeno, N, et al. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 2007; 8: 205–214.
Google Scholar | Crossref | Medline41. Kakizaki, S, Takagi, H, Murakami, M, et al. HLA Antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol 1999; 30: 794–800.
Google Scholar | Crossref | Medline42. Winsa, B, Adami, HO, Bergström, R, et al. Stressful life events and Graves’ disease. Lancet 1991; 338: 1475–1479.
Google Scholar | Crossref | Medline43. Chiovato, L, Pinchera, A. Stressful life events and Graves’ disease. Eur J Endocrinol 1996; 134: 680–682.
Google Scholar | Crossref | Medline44. Coles, AJ, Wing, M, Smith, S, et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999; 354: 1691–1695.
Google Scholar | Crossref | Medline | ISI45. Ruwhof, C, Drexhage, HA. Iodine and thyroid autoimmune disease in animal models. Thyroid 2001; 11: 427–436.
Google Scholar | Crossref | Medline46. Weetman, AP, McGregor, AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15: 788–830.
Google Scholar | Medline | ISI47. Hsieh, MC, Yu, ML, Chuang, WL, et al. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 2000; 142: 431–437.
Google Scholar | Crossref | Medline | ISI48. Lunel, F . Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology 1994; 107: 1550–1555.
Google Scholar | Crossref | Medline | ISI